I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 26 studies | 25% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 12 studies | 28% ± 11% | |
| CD16-positive, CD56-dim natural killer cell, human | 12 studies | 28% ± 7% | |
| gamma-delta T cell | 11 studies | 28% ± 11% | |
| CD8-positive, alpha-beta T cell | 11 studies | 20% ± 4% | |
| CD8-positive, alpha-beta memory T cell | 10 studies | 23% ± 4% | |
| mature NK T cell | 9 studies | 21% ± 5% | |
| platelet | 8 studies | 27% ± 7% | |
| plasmacytoid dendritic cell | 8 studies | 25% ± 7% | |
| T cell | 6 studies | 18% ± 2% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| innate lymphoid cell | 3 studies | 19% ± 1% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 23% ± 3% |
